BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT02089230-completion@plaintrial.com
DTSTAMP:20260928T153120Z
DTSTART;VALUE=DATE:20190605
SUMMARY:MEK Inhibitor 162 Relapsed and/or Refractory Acute Myeloid Leukemia
  (AML) and Poor Prognosis\, Not Suitable for or Unwilling to Receive Stand
 ard Therapy — estimated completion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT02089230
URL:https://plaintrial.com/trial/NCT02089230
END:VEVENT
END:VCALENDAR